These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38285336)

  • 21. In vitro teratogenicity testing using a 3D, embryo-like gastruloid system.
    Mantziou V; Baillie-Benson P; Jaklin M; Kustermann S; Arias AM; Moris N
    Reprod Toxicol; 2021 Oct; 105():72-90. PubMed ID: 34425190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation successes: chemicals.
    Spielmann H; Liebsch M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():33-40. PubMed ID: 12513649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of the evaluation method for teratogenicity using zebrafish embryos.
    Yamashita A; Inada H; Chihara K; Yamada T; Deguchi J; Funabashi H
    J Toxicol Sci; 2014 Jun; 39(3):453-64. PubMed ID: 24849680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy.
    Ornoy A
    Reprod Toxicol; 2007 Jul; 24(1):31-41. PubMed ID: 17548185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative embryotoxic potency of p-substituted phenols in the embryonic stem cell test (EST) and comparison to their toxic potency in vivo and in the whole embryo culture (WEC) assay.
    Strikwold M; Woutersen RA; Spenkelink B; Punt A; Rietjens IM
    Toxicol Lett; 2012 Sep; 213(2):235-42. PubMed ID: 22820428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acid.
    Riebeling C; Pirow R; Becker K; Buesen R; Eikel D; Kaltenhäuser J; Meyer F; Nau H; Slawik B; Visan A; Volland J; Spielmann H; Luch A; Seiler A
    Toxicol Sci; 2011 Apr; 120(2):360-70. PubMed ID: 21227905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
    Festag M; Viertel B; Steinberg P; Sehner C
    Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A selection of candidate compounds for in vitro teratogenesis test validation.
    Smith MK; Kimmel GL; Kochhar DM; Shepard TH; Spielberg SP; Wilson JG
    Teratog Carcinog Mutagen; 1983; 3(6):461-80. PubMed ID: 6140767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole embryo culture: a "New" technique that enabled decades of mechanistic discoveries.
    Ellis-Hutchings RG; Carney EW
    Birth Defects Res B Dev Reprod Toxicol; 2010 Aug; 89(4):304-12. PubMed ID: 20803690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of murine embryonic stem cells in embryotoxicity assays: the embryonic stem cell test.
    Seiler AE; Buesen R; Visan A; Spielmann H
    Methods Mol Biol; 2006; 329():371-95. PubMed ID: 16846005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of in vitro embryotoxicity tests for Chinese herbal medicines.
    Li L; Yin Tang L; Liang B; Wang R; Sun Q; Bik San Lau C; Chung Leung P; Fritsche E; Liebsch M; Seiler Wulczyn AEM; Spielmann H; Wang CC
    Reprod Toxicol; 2019 Oct; 89():45-53. PubMed ID: 31228572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of the teratogenicity of genistein and genistin using rat whole embryo culture and limbud micromass culture methods.
    Zou P; Xing L; Tang Q; Liu R; Hao W
    Food Chem Toxicol; 2012 Aug; 50(8):2831-6. PubMed ID: 22617716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screening.
    Palmer JA; Smith AM; Egnash LA; Conard KR; West PR; Burrier RE; Donley EL; Kirchner FR
    Birth Defects Res B Dev Reprod Toxicol; 2013 Aug; 98(4):343-63. PubMed ID: 24123775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cell and micromass culture in assessing developmental toxicity.
    Pratten M; Ahir BK; Smith-Hurst H; Memon S; Mutch P; Cumberland P
    Methods Mol Biol; 2012; 889():115-46. PubMed ID: 22669663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole embryo culture, teratogenesis, and the estimation of teratologic risk.
    New DA
    Teratology; 1990 Dec; 42(6):635-42. PubMed ID: 2087684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A high-throughput screen for teratogens using human pluripotent stem cells.
    Kameoka S; Babiarz J; Kolaja K; Chiao E
    Toxicol Sci; 2014 Jan; 137(1):76-90. PubMed ID: 24154490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclophosphamide and the Teratology Society: an awkward marriage.
    Ozolins TR
    Birth Defects Res B Dev Reprod Toxicol; 2010 Aug; 89(4):289-99. PubMed ID: 20803689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The embryonic stem cell test for the early selection of pharmaceutical compounds.
    Whitlow S; Bürgin H; Clemann N
    ALTEX; 2007; 24(1):3-7. PubMed ID: 17361315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daphnia magna as a Model Organism to Predict the Teratogenic Effect of Different Compounds.
    Mishra M
    Methods Mol Biol; 2024; 2753():261-281. PubMed ID: 38285344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Numeric Estimates of Teratogenic Severity from Embryo-Fetal Developmental Toxicity Studies.
    Wise LD
    Birth Defects Res B Dev Reprod Toxicol; 2016 Feb; 107(1):60-70. PubMed ID: 26848810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.